一项初步随机试验,针对患有糖尿病前期的成年人进行了基于异调的简短2型糖尿病预防计划
Eric Stice1, Paul Rohde2, Christopher D Desjardins1
1Stanford University, Stanford, California, USA.
Diabetes, obesity & metabolism
|January 8, 2025
概括
项目健康T2D计划有效降低了糖尿病前期的成年人体脂肪,体重和2型糖尿病 (T2D) 发病率. 这种不那么密集的干预显示出有希望的结果,因此需要在更大的试验中进行进一步的调查.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 预防医学 预防医学
背景情况:
- 糖尿病前期是发展2型糖尿病 (T2D) 的重要危险因素.
- 生活方式修改计划对于T2D预防至关重要.
- 需要有效和可访问的T2D预防策略.
研究的目的:
- 为了评估6周的2型糖尿病 (T2D) 预防计划的有效性,项目健康T2D.
- 将项目健康T2D与糖尿病前期成人教育视频控制进行比较.
- 评估身体组成,体重和血糖标记物的变化.
主要方法:
- 一项初步随机试验,涉及62名糖尿病前期成年人.
- 参与者被随机分配到团队交付的项目健康T2D干预或教育视频控制中.
- 测量是在基线,干预后和3个月后期进行的.
主要成果:
- 与对照组相比,干预组的身体脂肪,体重和BMI显著减少.
- 干预组的参与者经历了显著的瘦肉量增加.
- 观察到HbA1c的边际降低和T2D发病率下降的趋势.
结论:
- 项目健康T2D在减少身体脂肪,体重和T2D发病率方面表现出令人鼓舞的结果.
- 该计划还导致瘦肉量有好处地增加.
- 它的不那么密集的性质表明其应用范围更广泛的潜力,并保证在更大的疗效试验中进行评估.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
501
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
501
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


